Patients with BC with high IGF2BP1 expression had significantly higher levels of CD274, CTLA4, HAVCR2, LAG3, PDCD1, PDCD1LG2, and TIGIT (Additional file 1: Fig. S11B). Here, TIGIT is linked to breast cancer.